Harper Molly - Insider Non-Derivative Transactions at CATALYST PHARMACEUTICALS, INC. (CPRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 3, 2024, Harper Molly's relationship to CATALYST PHARMACEUTICALS, INC. (CPRX) is Director, and currently has 0 shares of Common Stock, par value $0.001 per share.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CPRX insiders.

Data Source: SEC.
Harper Molly - Insider Non-Derivative Transactions of CPRX Common Stock, par value $0.001 per share
Harper Molly - Insider Non-Derivative Transactions at CPRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 4, 2024 Sell -- (Common Stock, par value $0.001 per share) 5333 16.3 0
Feb 16, 2024 M -- (Common Stock, par value $0.001 per share) 4000 0 5333
Dec 28, 2023 M -- (Common Stock, par value $0.001 per share) 1333 0 1333
Dec 16, 2023 Sell -- (Common stock, par value $0.001 per share) 10000 14.37 0
Dec 16, 2023 Sell -- (Common stock, par value $0.001 per share) 4000 14.43 0
Dec 16, 2023 M -- (Common stock, par value $0.001 per share) 10000 5.78 10000
Feb 16, 2023 M -- (Common Stock, par value $0.001 per share) 4000 0 4000